HDAC-IN-98
Based on 1 Customer Validation
HDAC-IN-98 is a HDAC1, HDAC2, HDAC3 inhibitor (one of the most selective class I HDAC inhibitors) with human IC50 values of 41.2 nM, 52.5 nM, and 74.3 nM respectively. HDAC-IN-98 induces H3K9 acetylation, p21 upregulation, G2/M arrest, cell apoptosis, has strong antiproliferative effects in colorectal cancer cells, low toxicity in healthy colon epithelium, modulates short-term in vitro effects via autophagy, and shows strong antitumor efficacy in vivo in the chorioallantoic membrane model (CAM) assay. HDAC-IN-98 can be used for the research of colorectal cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.36%
- CAS No.: 3124773-51-6
- Formule: C24H21N3O4
- Masse moléculaire:415.44
-
Stockage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Activité biologique
Description
IC50 & Target
|
hHDAC1 41.2 nM (IC50) |
hHDAC2 52.5 nM (IC50) |
hHDAC3 74.3 nM (IC50) |
hHDAC6 >10000 nM (IC50) |
hHDAC8 >10000 nM (IC50) |
hHDAC10 4261 nM (IC50) |
hHDAC11 >10000 nM (IC50) |
In Vitro
HDAC-IN-98 (compound 5d) selectively inhibits class I HDAC enzymes (HDAC1, HDAC2, HDAC3) with sub-nanomolar to low-nanomolar IC50 values and weak or no activity against other HDAC isoforms (IC50: HDAC1 = 41.2 nM, HDAC2 = 52.5 nM, HDAC3 = 74.3 nM, HDAC10 = 4261 nM, HDAC5/8/11 >10000 nM)[1].
HDAC-IN-98 (1 μM; up to 60 min) inhibits total HDAC activity in a complex nuclear extract system[1].
HDAC-IN-98 (0.1-100 μM; 48 h) selectively reduces viability of CRC cells with IC50 values ranging from 14 μM and minimal toxicity to normal colon cells (IC50: HCT116 = 1 μM, HT29 = 4 μM, DLD1 = 4 μM, HCEC >100 μM)[1].
HDAC-IN-98 (1-4 μM; 48 h) modulates epigenetic markers (H3K9 acetylation) and apoptotic pathways (PARP cleavage) in CRC cells without inhibiting class II HDACs[1].
HDAC-IN-98 (1-4 μM; 48 h) disrupts cell cycle progression, inducing subG1 accumulation (apoptosis) in HCT116 and G1 arrest in HT29/DLD1 cells[1].
HDAC-IN-98 (1-4 μM; 48 h) triggers apoptosis selectively in HCT116 cells without inducing necrosis[1].
HDAC-IN-98 (up to 10 μM) shows minimal hERG liability at concentrations relevant to its anticancer activity[1].
HDAC-IN-98 (1 μM; in vitro pretreatment; 48 h) exhibits potent antitumor efficacy in chicken embryos with colorectal cancer chorioallantoic membrane model (CAM) models independent of p21 status. In the HCT116 p21 wildtype CAM model, HDAC-IN-98 confirmes a robust upregulation of p21. In the HCT116 p21−/− CAM model, HDAC-IN-98 significantly reduces the vessel area, the vessel length, and the number of branching points whereas the vessel thickness is not affected[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Colorectal Cancer Cell Lines (HCT116, HT29, DLD1) and Normal Colon Epithelial Cells (HCEC)
-
Concentration:0.1-100 μM
-
Incubation Time:48 h
-
Result:Showed dose-dependent cytotoxicity with an IC₅₀ of 1 μM (HCT116); showed dose-dependent cytotoxicity with an IC₅₀ of 4 μM (HT29); showed dose-dependent cytotoxicity with an IC₅₀ of 4 μM (DLD1); showed low toxicity in HCEC with an IC₅₀ >100 μM
-
Cell Line:CRC Cell Lines (HCT116, HT29, DLD1)
-
Concentration:1 μM, 4 μM
-
Incubation Time:48 h
-
Result:Slightly increased H3K9 acetylation in HCT116 cells; did not affect HDAC1/HDAC6 protein levels or α-tubulin acetylation; upregulated p21 in HCT116 cells; induced PARP cleavage in HCT116/HT29 cells.
-
Cell Line:CRC Cell Lines (HCT116, HT29, DLD1)
-
Concentration:1 μM, 4 μM
-
Incubation Time:48 h
-
Result:Induced subG1 accumulation (apoptosis) in HCT116 cells; increased G1-phase population in HT29/DLD1 cells; reduced S-phase population across all lines; correlated with upregulated p21 and reduced Cyclin B1 in HCT116 cells.
-
Cell Line:CRC Cell Lines (HCT116, HT29, DLD1)
-
Concentration:1 μM, 4 μM
-
Incubation Time:48 h
-
Result:Induced significant apoptosis in HCT116 cells (Annexin V-positive/PI-negative cells); induced minimal apoptosis in HT29/DLD1 cells; showed no necrosis.
Chemical Information
-
CAS No. 3124773-51-6
-
Appearance Solid
-
Masse moléculaire 415.44
-
Formule C24H21N3O4
-
Color White to off-white
-
SMILES
O=C(/C=C/C1=CC2=C(C=C1)OCO2)NCC3=CC=C(C=C3)C(NC4=CC=CC=C4N)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
In Vitro:
DMSO : 50 mg/mL (120.35 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocole
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Patient-Derived Xenograft (PDX)
Patient-derived xenograft (PDX) models are generated by engrafting primary human tumor tissue directly into immunodeficient mice, allowing in vivo propagation of patient tumor biology without initial in vitro adaptation. These models are used to preserve key histopathological and molecular characteristics of the original tumor and enable assessment of tumor growth dynamics and therapeutic response in a living organism. The biological readout is tumor engraftment and subsequent growth in the murine host, which reflects the ability of human tumor cells to survive, vascularize, and expand in an immunocompromised microenvironment.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
-
Fiche technique (276 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.4071 mL | 12.0354 mL | 24.0709 mL | 60.1772 mL |
| 5 mM | 0.4814 mL | 2.4071 mL | 4.8142 mL | 12.0354 mL | |
| 10 mM | 0.2407 mL | 1.2035 mL | 2.4071 mL | 6.0177 mL | |
| 15 mM | 0.1605 mL | 0.8024 mL | 1.6047 mL | 4.0118 mL | |
| 20 mM | 0.1204 mL | 0.6018 mL | 1.2035 mL | 3.0089 mL | |
| 25 mM | 0.0963 mL | 0.4814 mL | 0.9628 mL | 2.4071 mL | |
| 30 mM | 0.0802 mL | 0.4012 mL | 0.8024 mL | 2.0059 mL | |
| 40 mM | 0.0602 mL | 0.3009 mL | 0.6018 mL | 1.5044 mL | |
| 50 mM | 0.0481 mL | 0.2407 mL | 0.4814 mL | 1.2035 mL | |
| 60 mM | 0.0401 mL | 0.2006 mL | 0.4012 mL | 1.0030 mL | |
| 80 mM | 0.0301 mL | 0.1504 mL | 0.3009 mL | 0.7522 mL | |
| 100 mM | 0.0241 mL | 0.1204 mL | 0.2407 mL | 0.6018 mL |